Combination of Reverse and Chemical Genetic Screens Reveals Angiogenesis Inhibitors and Targets

Chemistry and Biology

Volumn 16, Issue 4, 2009, Pages 432-441

  Kalén, Mattias ^a,b   Wallgard, Elisabet ^a,b   Asker, Noomi ^a   Nasevicius, Aidas ^c   Athley, Elisabet ^a   Billgren, Erik ^a   Larson, Jon D ^c   Wadman, Shannon A ^c   Norseng, Elizabeth ^a   Clark, Karl J ^c   He, Liqun ^b   Karlsson Lindahl, Linda ^a   Häger, Ann Katrin ^a   Weber, Holger ^d   Augustin, Hellmut ^d   Samuelsson, Tore ^e   Kemmet, Chelsy K ^f   Utesch, Carly M ^f   Essner, Jeffrey J ^c,f   Hackett, Perry B ^c   Hellström, Mats ^a,b   more..

^a AngioGenetics Sweden AB   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Discovery Genomics Inc   (United States)

^d TUMOR BIOLOGY CENTER   (Germany)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f IOWA STATE UNIVERSITY   (United States)

Author keywords

CELLBIO; CHEMBIO; SIGNALING

Indexed keywords

7 OXABICYCLO[2.2.1]HEPTANE 2,3 DICARBOXYLIC ACID DISODIUM; ANGIOGENESIS INHIBITOR; DICARBOXYLIC ACID; PHOSPHOPROTEIN PHOSPHATASE;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; ZEBRA FISH;

ANGIOGENESIS INHIBITORS; ANIMALS; CELLS, CULTURED; DICARBOXYLIC ACIDS; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOPROTEIN PHOSPHATASES; ZEBRAFISH;

DANIO RERIO; MUS; VERTEBRATA;

EID: 65249138983     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2009.02.010     Document Type: Article

References (51)

1. Adams R.H., and Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8 (2007) 464-478
2. Andreoli C.M., and Miller J.W. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr. Opin. Ophthalmol. 18 (2007) 502-508
3. Bahary N., Goishi K., Stuckenholz C., Weber G., Leblanc J., Schafer C.A., Berman S.S., Klagsbrun M., and Zon L.I. Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish. Blood 110 (2007) 3627-3636
4. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc. B (Methodological) 57 (1995) 289-300
5. Bondjers C., He L., Takemoto M., Norlin J., Asker N., Hellstrom M., Lindahl P., and Betsholtz C. Microarray analysis of blood microvessels from PDGF-B and PDGF-Rβ mutant mice identifies novel markers for brain pericytes. FASEB J. 20 (2006) 1703-1705
6. Bostrom H., Willetts K., Pekny M., Leveen P., Lindahl P., Hedstrand H., Pekna M., Hellstrom M., Gebre-Medhin S., Schalling M., et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85 (1996) 863-873
7. Casanovas O., Hicklin D.J., Bergers G., and Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8 (2005) 299-309
8. Cha Y.R., and Weinstein B.M. Visualization and experimental analysis of blood vessel formation using transgenic zebrafish. Birth Defects Res. C Embryo Today 81 (2007) 286-296
9. Chan J., Bayliss P.E., Wood J.M., and Roberts T.M. Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 1 (2002) 257-267
10. Cohen P.T. Protein phosphatase 1-targeted in many directions. J. Cell Sci. 115 (2002) 241-256
11. Cohen P.T., Philp A., and Vazquez-Martin C. Protein phosphatase 4-from obscurity to vital functions. FEBS Lett. 579 (2005) 3278-3286
12. Cohen P.T.W. Overview of protein serine/threonine phosphatases. In: Arino J., and Alexander D.R. (Eds). Topics in Current Genetics: Protein Phosphatases (2004), Springer-Verlag, Berlin, Heidelberg 1-20
13. Cui X., and Churchill G.A. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol. 4 (2003) 210
14. Eggert U.S., Kiger A.A., Richter C., Perlman Z.E., Perrimon N., Mitchison T.J., and Field C.M. Parallel chemical genetic and genome-wide RNAi screens identify cytokinesis inhibitors and targets. PLoS Biol. 2 (2004) e379
15. Ekker S.C. Morphants: a new systematic vertebrate functional genomics approach. Yeast 17 (2000) 302-306
16. Eldridge R., and Casida J.E. Cantharidin effects on protein phosphatases and the phosphorylation state of phosphoproteins in mice. Toxicol. Appl. Pharmacol. 130 (1995) 95-100
17. Ellis L.M., and Hicklin D.J. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 8 (2008) 579-591
18. Erdodi F., Toth B., Hirano K., Hirano M., Hartshorne D.J., and Gergely P. Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo. Am. J. Physiol. 269 (1995) C1176-C1184
19. Eskens F.A., and Verweij J. The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review. Eur. J. Cancer 42 (2006) 3127-3139
20. Ferrara N., Hillan K.J., Gerber H.P., and Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov. 3 (2004) 391-400
21. Fong T.A., Shawver L.K., Sun L., Tang C., App H., Powell T.J., Kim Y.H., Schreck R., Wang X., Risau W., et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 59 (1999) 99-106
22. Gaengel K., Genové G., Armulik A., and Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol. (2009) 10.1161/ATVBAHA.107.161521 in press. Published online January 22, 2009
23. Hartel F.V., Rodewald C.W., Aslam M., Gunduz D., Hafer L., Neumann J., Piper H.M., and Noll T. Extracellular ATP induces assembly and activation of the myosin light chain phosphatase complex in endothelial cells. Cardiovasc. Res. 74 (2007) 487-496
24. Knapp J., Boknik P., Luss I., Huke S., Linck B., Luss H., Muller F.U., Muller T., Nacke P., Noll T., et al. The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability. J. Pharmacol. Exp. Ther. 289 (1999) 1480-1486
25. Knapp J., Boknik P., Linck B., Luss H., Muller F.U., Petertonjes L., Schmitz W., and Neumann J. Cantharidin enhances norepinephrine-induced vasoconstriction in an endothelium-dependent fashion. J. Pharmacol. Exp. Ther. 294 (2000) 620-626
26. Korff T., and Augustin H.G. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell Biol. 143 (1998) 1341-1352
27. Korff T., and Augustin H.G. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J. Cell Sci. 112 (1999) 3249-3258
28. Kung H.N., Chien C.L., Chau G.Y., Don M.J., Lu K.S., and Chau Y.P. Involvement of NO/cGMP signaling in the apoptotic and anti-angiogenic effects of β-lapachone on endothelial cells in vitro. J. Cell. Physiol. 211 (2007) 522-532
29. Kwon H.J. Discovery of new small molecules and targets towards angiogenesis via chemical genomics approach. Curr. Drug Targets 7 (2006) 397-405
30. Larson J.D., Wadman S.A., Chen E., Kerley L., Clark K.J., Eide M., Lippert S., Nasevicius A., Ekker S.C., Hackett P.B., et al. Expression of VE-cadherin in zebrafish embryos: a new tool to evaluate vascular development. Dev. Dyn. 231 (2004) 204-213
31. Li L., Kozlowski K., Wegner B., Rashid T., Yeung T., Holmes C., and Ballermann B.J. Phosphorylation of TIMAP by glycogen synthase kinase-3β activates its associated protein phosphatase 1. J. Biol. Chem. 282 (2007) 25960-25969
32. Li Y.M., Mackintosh C., and Casida J.E. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues. Biochem. Pharmacol. 46 (1993) 1435-1443
33. Martyn U., and Schulte-Merker S. Zebrafish neuropilins are differentially expressed and interact with vascular endothelial growth factor during embryonic vascular development. Dev. Dyn. 231 (2004) 33-42
34. Nasevicius A., and Ekker S.C. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26 (2000) 216-220
35. Oh S.P., Seki T., Goss K.A., Imamura T., Yi Y., Donahoe P.K., Li L., Miyazono K., ten Dijke P., Kim S., et al. Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97 (2000) 2626-2631
36. Ridgway J., Zhang G., Wu Y., Stawicki S., Liang W.C., Chanthery Y., Kowalski J., Watts R.J., Callahan C., Kasman I., et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444 (2006) 1083-1087
37. Romano M., and Claria J. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J. 17 (2003) 1986-1995
38. Ross-Macdonald P. Forward in reverse: how reverse genetics complements chemical genetics. Pharmacogenomics 6 (2005) 429-434
39. Scheidl S.J., Nilsson S., Kalen M., Hellstrom M., Takemoto M., Hakansson J., and Lindahl P. mRNA expression profiling of laser microbeam microdissected cells from slender embryonic structures. Am. J. Pathol. 160 (2002) 801-813
40. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., and Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-66
41. Shinoki N., Sakon M., Kambayashi J., Ikeda M., Oiki E., Okuyama M., Fujitani K., Yano Y., Kawasaki T., and Monden M. Involvement of protein phosphatase-1 in cytoskeletal organization of cultured endothelial cells. J. Cell. Biochem. 59 (1995) 368-375
42. Soares M.B., Bonaldo M.F., Jelene P., Su L., Lawton L., and Efstratiadis A. Construction and characterization of a normalized cDNA library. Proc. Natl. Acad. Sci. USA 91 (1994) 9228-9232
43. Tran T.C., Sneed B., Haider J., Blavo D., White A., Aiyejorun T., Baranowski T.C., Rubinstein A.L., Doan T.N., Dingledine R., et al. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res. 67 (2007) 11386-11392
44. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., and DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998) 705-716
45. Valdimarsdottir G., Goumans M.J., Itoh F., Itoh S., Heldin C.H., and ten Dijke P. Smad7 and protein phosphatase 1α are critical determinants in the duration of TGF-β/ALK1 signaling in endothelial cells. BMC Cell Biol. 7 (2006) 16
46. Visel A., Thaller C., and Eichele G. GenePaint.org: an atlas of gene expression patterns in the mouse embryo. Nucleic Acids Res. 32 (2004) D552-D556
47. Wallgard E., Larsson E., He L., Hellstrom M., Armulik A., Nisancioglu M.H., Genove G., Lindahl P., and Betsholtz C. Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1469-1476
48. Wang E., Miller L.D., Ohnmacht G.A., Liu E.T., and Marincola F.M. High-fidelity mRNA amplification for gene profiling. Nat. Biotechnol. 18 (2000) 457-459
49. Wang G.S. Medical uses of mylabris in ancient China and recent studies. J. Ethnopharmacol. 26 (1989) 147-162
50. Young M.R., Kolesiak K., and Meisinger J. Protein phosphatase-2A regulates endothelial cell motility and both the phosphorylation and the stability of focal adhesion complexes. Int. J. Cancer 100 (2002) 276-282
51. Zhu X., Wu S., Dahut W.L., and Parikh C.R. Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am. J. Kidney Dis. 49 (2007) 186-193